GEMIFLOXACIN MESYLATE Drug Patent Profile
✉ Email this page to a colleague
When do Gemifloxacin Mesylate patents expire, and what generic alternatives are available?
Gemifloxacin Mesylate is a drug marketed by Orbion Pharms and is included in one NDA.
The generic ingredient in GEMIFLOXACIN MESYLATE is gemifloxacin mesylate. There are two drug master file entries for this compound. Additional details are available on the gemifloxacin mesylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GEMIFLOXACIN MESYLATE?
- What are the global sales for GEMIFLOXACIN MESYLATE?
- What is Average Wholesale Price for GEMIFLOXACIN MESYLATE?
Summary for GEMIFLOXACIN MESYLATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Patent Applications: | 2,430 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GEMIFLOXACIN MESYLATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for GEMIFLOXACIN MESYLATE
Paragraph IV (Patent) Challenges for GEMIFLOXACIN MESYLATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
FACTIVE | Tablets | gemifloxacin mesylate | 320 mg | 021158 | 1 | 2008-03-04 |
US Patents and Regulatory Information for GEMIFLOXACIN MESYLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orbion Pharms | GEMIFLOXACIN MESYLATE | gemifloxacin mesylate | TABLET;ORAL | 090466-001 | Jun 15, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |